@conference{28ce0241bd214dfb8ce3325b0c18d215,
title = "Abstract 4674: Pilot study of intrahepatic artery chemotherapy in combination with sorafenib in hepatocellular carcinoma patients.",
author = "Feun, {Lynn G.} and Govindarajan Narayanan and Jose Yrizarry and Vy Dinh and Niramol Savaraj and Christopher O'Brien and Paul Martin",
note = "Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Background: Sorafenib and chemoembolization of the liver (TACE) have both produced increased survival in patients (pts) with hepatocellular carcinoma (HCC). However, not all HCC pts can tolerate or accept TACE due to portal vein thrombosis or risk of liver failure.Chemotherapy infused via intrahepatic artery infusion (IA) may potentially increase drug delivery to the tumor while reducing systemic toxicity.; AACR 104th Annual Meeting ; Conference date: 01-04-2013",
year = "2013",
month = apr,
doi = "10.1158/1538-7445.AM2013-4674",
language = "American English",
}